|
Advanced Life Sciences Applies for Fast-Track Designation for Restanza
Advanced Life Sciences on Wednesday announced that the company has applied to the FDA for fast-track designation for Restanza, a novel once-daily oral antibiotic, for the treatment of community acquired bacterial pneumonia.
StreetInsider |
Register Now
Archives